Characteristic | Total (N = 91) |
Spinal pathology | |
Herniated nucleus pulposus | 86.8% (79) |
Central spinal stenosisa | 6.6% (6) |
Degenerative disk diseasea | 6.6% (6) |
Neuropathy | |
Radiculopathy | 15.5% (15) |
Myelopathy | 1.1% (1) |
Myeloradiculopathy | 83.3% (75) |
Number of operative levels | |
1 level | 62.6% (57) |
2 levels | 37.4% (34) |
Operative level | |
C5-C6 | 29.7% (27) |
C6-C7 | 30.8% (28) |
C7-T1 | 2.2% (2) |
C5-C7 | 35.2% (32) |
C6-T1 | 2.2% (2) |
Cervical plating | |
Standalone cage | 36.3% (33) |
Anterior plate | 63.7% (58) |
Operative time, min, mean ± SD | 55.3 ± 15.3 |
Estimated blood loss, mL mean ± SD | 28.3 ± 11.3 |
Length of stay, h, mean ± SD | 9.9 ± 7.5 |
Day of discharge | |
POD 0 | 83.1% (74) |
POD 1 | 16.9% (15) |
In-hospital complications | |
Urinary retentionb | 1.0% (1) |
Tracheoesophageal hematomac | 1.0% (1) |
Abbreviation: POD, postoperative day.
Note: Data presented as % (n) unless otherwise indicated.
↵a Stenosis not attributed to a herniated nucleus pulposus
↵b One patient demonstrated a postvoid residual volume of 300 mL on POD 0. The patient required straight catheterization and was placed on Flomax. The patient was able to void spontaneously on POD 2.
↵c One patient had an expanding superficial hematoma while in the postoperative recovery area. An emergent evacuation of a pretracheal hematoma was performed. The patient was discharged safely home on POD 1.